Furthermore, the findings of this study suggest that targeting the miRNA-mediated regulation of Hsd11b2 mRNA expression could be a potential therapeutic strategy for preventing or treating metabolic disorders associated with DOHaD. This evidence concerns the gene HSD11B2 and Other metabolic disease.